JPH01235581A - Novel pseudomonas bacteria - Google Patents
Novel pseudomonas bacteriaInfo
- Publication number
- JPH01235581A JPH01235581A JP6128488A JP6128488A JPH01235581A JP H01235581 A JPH01235581 A JP H01235581A JP 6128488 A JP6128488 A JP 6128488A JP 6128488 A JP6128488 A JP 6128488A JP H01235581 A JPH01235581 A JP H01235581A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- pseudomonas
- strains
- bacteria
- bacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000589516 Pseudomonas Species 0.000 title claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 31
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 28
- 230000001580 bacterial effect Effects 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 abstract description 10
- 239000001963 growth medium Substances 0.000 abstract description 5
- 230000003248 secreting effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 24
- 241000193830 Bacillus <bacterium> Species 0.000 description 11
- 239000002609 medium Substances 0.000 description 7
- 241000589774 Pseudomonas sp. Species 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- 108090000637 alpha-Amylases Proteins 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000004139 alpha-Amylases Human genes 0.000 description 3
- 229940024171 alpha-amylase Drugs 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 108050001049 Extracellular proteins Proteins 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 235000021245 dietary protein Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 239000012770 industrial material Substances 0.000 description 2
- 239000002649 leather substitute Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、新規なシュードモナス属菌に間するものであ
る。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel Pseudomonas bacterium.
従来、−mに蛋白質を微生物によって生産させるという
場合、微生物を培養し、微生物菌体を磨砕後、蛋白質を
抽出、精製することにより得ていた。Conventionally, when protein is produced by a microorganism in -m, the protein has been obtained by culturing the microorganism, grinding the microorganism cells, and then extracting and purifying the protein.
また、一般に遺伝子組換えの微生物生産の宿主としては
、大腸菌が主に使用されているが、大腸菌では、組換え
遺伝子によって合成されるペプチドや蛋白質は細胞内に
とどまり培地中に分泌生産されないため、自づとその生
産量は制限されていた。In addition, Escherichia coli is generally used as a host for genetically modified microorganism production, but in Escherichia coli, the peptides and proteins synthesized by recombinant genes remain within the cells and are not secreted into the culture medium. Naturally, its production was limited.
その上、細胞磨砕によりペプチド、蛋白質を抽出113
することは、操作が煩雑になるなどの欠9点が措摘され
ている。Furthermore, peptides and proteins can be extracted by cell trituration113
However, nine drawbacks have been identified, including that the operation becomes complicated.
鵜高は、先に、遺伝子組換えにおける宿主菌として蛋白
質を菌体外に分泌する微生物を求めて研究した結果、蛋
白質を多量に分泌生産する微生物として、約1 、20
0株のなかからバチルス・プレビス(Bacillus
brevis) 4株、新菌株バチルス・フロテイホ
ーマンス(Bacillus proteifor+m
ans)1株の計5株を分離同定するに至った。 [
Agric、Biol。Udaka previously researched microorganisms that secrete proteins outside of their cells as host bacteria for genetic recombination, and found that they were found to be microorganisms that secrete and produce large amounts of proteins.
Bacillus plevis (Bacillus plevis) was selected from 0 strains.
brevis) 4 strains, new strain Bacillus proteifor+m
Ans) A total of 5 strains, 1 strain, were isolated and identified. [
Agric, Biol.
Che+++、、40 (3)、 523−528(1
976)]また、一方、分泌宿主−ベクターとして枯草
菌も利用され、α−アミラーゼ、インターフェロンなど
各種異種蛋白質を培地中に蓄積させることに成功してい
るが、菌体内外の強い10テアーゼにより生産量が制限
されたり、分解されたりして、良好な結果は得られてい
ない。Che+++, 40 (3), 523-528 (1
[976] On the other hand, Bacillus subtilis has also been used as a secretion host-vector, and various heterologous proteins such as α-amylase and interferon have been successfully accumulated in the culture medium. Good results have not been achieved due to limited amounts or decomposition.
先に、鵜高らは、バチルス・ステアロサーモフィルス(
Bacillus stearothermophil
us) DY−5の耐熱性α−アミラーゼ遺伝子をプラ
スミド pUBlloに組込んだpBAM10+を保有
するバチルス−プレビス47及び枯草菌を37℃、48
時間培養した時、バチルス・プレビス47では約15.
o00U/+++I、枯草菌では3,000υ/III
I程度のα−アミラーゼをそれぞれ培地中に生産MFa
するのを確認した。 [J、Bacteriol、
、 164゜<31,1132−1187(1985)
]ここに、全く同一の1ラスミドを保有するバチルス・
プレビス47と枯草菌とでは、耐熱性α−アミラーゼの
生産においてバチルス・プレビス47の方が約5倍も生
産効率のよいという事実から蛋白質生産菌の有する蛋白
質分泌能を用いることにより異種遺伝子産物を効率良く
分泌生産させうろことが判明した。Previously, Udaka et al.
Bacillus stearothermophil
us) Bacillus plevis 47 carrying pBAM10+ in which the thermostable α-amylase gene of DY-5 was incorporated into the plasmid pUBllo and Bacillus subtilis were incubated at 37°C and 48°C.
When cultured for an hour, Bacillus plevis 47 was about 15.
o00U/+++I, 3,000υ/III for Bacillus subtilis
MFa produces approximately I α-amylase in the culture medium.
I confirmed that it does. [J, Bacteriol,
, 164゜<31, 1132-1187 (1985)
]Here, Bacillus possessing exactly the same 1 lasmid.
Based on the fact that Bacillus plevis 47 is about 5 times more efficient in producing heat-stable α-amylase than Bacillus subtilis, it is possible to produce a heterologous gene product by using the protein secretion ability of protein-producing bacteria. It was found that secretion and production can be carried out efficiently.
そこで、本発明者らは、蛋白質を著量分泌しする苗が遺
伝子聞損えにおける宿主菌としてすぐれたものであると
の発想から、このような菌株を求めて鋭意2別を行った
ところ、各種資料から分離した約 100.000株の
なかから菌体外に著量の蛋白質を生産する株を単離した
。Therefore, based on the idea that seedlings that secrete a large amount of protein are excellent host bacteria for gene loss, the inventors conducted a thorough search for such strains, and found that Out of approximately 100,000 strains isolated from various materials, we isolated a strain that produces a significant amount of protein outside the bacterial body.
ここに単離された株について、種の同定を行ったところ
、はとんどはバチルス属に−するものと同定された。When the strains isolated here were identified by species, most of them were identified as belonging to the genus Bacillus.
本発明者等は、更にii芭選別を行ったところ、バチル
ス属以外にも、蛋白質を著量に菌体外に分泌生産する菌
株を単層することに成功したのである。ここに単離され
た株について、種の同定を行ったところ、シュードモナ
ス属に属するものと同定され1本発明を完成するに到っ
た。The present inventors further performed ii selection and succeeded in creating a monolayer of strains other than those of the genus Bacillus that secrete and produce a significant amount of protein outside the bacterial cells. When the strain isolated here was identified as belonging to the genus Pseudomonas, the present invention was completed.
本発明は、菌体外に著量の蛋白質を生産するシュードモ
ナスvL菌である。The present invention is a Pseudomonas vL bacterium that produces a significant amount of protein extracellularly.
従来、バチルス属において、蛋白質を生産する菌株は知
られているが、シュードモナス属菌で蛋白質す5 g/
を以上もの著1菌体外に生産する苗株は知られていない
。Conventionally, strains of Bacillus that produce proteins have been known, but Pseudomonas strains produce protein at a rate of 5 g/
There are no known seedlings that produce these types of bacteria outside the bacterial body.
本発明においてはじめて分離された新菌株、即ち、菌体
外に著量の蛋白質を生産するシュードモナス属の新菌株
は全く新規である。The new strain isolated for the first time in the present invention, ie, the new strain of the genus Pseudomonas that produces a significant amount of protein outside the bacterial body, is completely new.
本発明においては、蛋白質を5gハ以上培地中に分泌生
産する菌株を目標に選択分離された。In the present invention, strains that secrete and produce 5 g or more of protein into the medium were selected and isolated.
まず、土壌などの試料から分離された約100.000
株の菌株をT2寒天平板培地(1%グルコース、1%^
プトン、0.5%肉エキス、0.2%酵母エキス、1.
5%寒天末、pH7,0)に接種し、平板培地上でコロ
ニー周辺が5%過塩素酸により白濁する!I菌を選択し
た6次に、ここに分離した細菌株をT2液体培地(15
0m1容三角フラスコ、培地量10m1 )でS盪培養
(30℃、48時閘)し、その培養r液中に1.2g/
1以上の蛋白質を生産する菌株を80株得々菌体外蛋白
質の測定においては、培養液に等IのQ、2N NaO
Hを加え攪拌後10.OOOrpm X 5分遠心分離
処理して菌体を除き、上清に等量の10%トリクロル酢
酸を加えてlO分後3.000rpn+X io分間遠
心分離して沈殿を集め、IN Mailで溶解した後L
owry法[J、Biol、Ches、 193.26
5(1951)]によって定量し蛋白質量は牛血清アル
ブミンとして換算した。First, approximately 100,000
The strains were grown on T2 agar plates (1% glucose, 1%^
Pton, 0.5% meat extract, 0.2% yeast extract, 1.
5% agar powder, pH 7.0) is inoculated, and the area around the colony becomes cloudy due to 5% perchloric acid on a plate medium! Next, the bacterial strain isolated here was transferred to T2 liquid medium (15
Culture in S shake culture (30°C, 48 hours) in a 0ml Erlenmeyer flask (medium volume 10ml), and add 1.2g/ml to the culture solution.
80 strains that produce at least one protein were obtained.For the measurement of extracellular proteins, the culture solution was mixed with equal amount of Q, 2N NaO.
After adding H and stirring 10. Centrifuge for 5 minutes at OOOrpm to remove bacterial cells, add an equal volume of 10% trichloroacetic acid to the supernatant, and after 10 minutes, centrifuge at 3,000 rpm + Xio to collect the precipitate, dissolve it with IN Mail, and then
owry method [J, Biol, Ches, 193.26
5 (1951)], and the protein amount was converted into bovine serum albumin.
蛋白質高生産培地として第1表に示す培地を選んだ。The medium shown in Table 1 was selected as a high protein production medium.
第1表 蛋白質高生産培地
これらの5種類の培地のすべての培地に、先に得られた
80株の菌を振盪培養し、いずれかの培地で菌体外蛋白
質を5gハ以上生産する菌株を31株選択した。Table 1 High protein production medium The 80 strains obtained earlier were cultured with shaking in all of these five types of media, and strains that produced 5 g or more of extracellular protein in any of the media were cultured. 31 stocks were selected.
これら31株を、 Bergey’s Manual
of Detern+1−native Bacte
riology (第8版) 、 Bergey’Ma
nual of 5yste+natic Bacte
rioligy vol、l及び、TheProkar
yote (A Handbook on )Iabi
tats。These 31 strains are listed in Bergey's Manual
of Detern+1-native Bacte
riology (8th edition), Bergey'Ma
natural of 5yste+natic bacte
rioligy vol.l and TheProkar
yote (A Handbook on)Iabi
tats.
l5olation and Identificat
ion of Bacteria)によって同定したと
ころ、6株は、まず、好気性、ダラム染色陰性、桿菌、
胞子を形成しない点においてシュードモナス属に属する
ものと認められたそのうち、)1501株をその他の形
態的性質、各培地における生育状態、生理学的性質につ
いて、シュードモナス属の従来知られている菌種と比較
検討した結果、シュードモナス属のどの菌種とも異って
いた。l5olation and identification
ion of Bacteria), the six strains were initially aerobic, Durham stain negative, bacilli,
Strain 1501, which was recognized as belonging to the genus Pseudomonas in that it does not form spores, was compared with previously known bacterial species of the genus Pseudomonas in terms of other morphological properties, growth conditions in various media, and physiological properties. As a result of examination, it was found that it was different from any other bacterial species in the genus Pseudomonas.
従って、本菌種はシュードモナス属の新1i111とし
て同定された。Therefore, this bacterial species was identified as a new 1i111 of the genus Pseudomonas.
かくて、本菌種はシュードモナスsp、H3O1と命名
された。シュードモナスsp、H3O1はFERM P
−9742として微工研に寄託されている。Thus, this bacterial species was named Pseudomonas sp, H3O1. Pseudomonas sp, H3O1 is FERM P
-9742 and has been deposited with the Institute of Fine Technology.
次にシュードモナス sp、 )1501の国学的性質
を示す。Next, we will show the national characteristics of Pseudomonas sp.) 1501.
(B)各培地における生りt状聾
〈c+ffi埋7的す
つづきあり
(D>酸及びガスの生成
(E)炭素源の資化性
Acetate +5ucc
1nate +Fumarate
−L−Malate
+β−Hydroxybutylate
+Lactate
+C1trate +置−Ke
toglutarate −Glycer
ol +しAlanine
+L−Aspartate
−L−Glutasate
+しArginine −L−Pr
oline 十
L−Tyrosine +D−Fu
cose −Ma
ltose −
Cellobiosc
−Lactose
−O−八rabinose
−^rabitol +
5tarch
−Inulin ト
0xalate
−Ethyle++ glycol
−L−Threonine
−D−Ribose
+Mannitol +D−X
ylose ト
レ^rabinose 十L−Rha
mnose −Gluc
ose 十
D−Mannose +
1l−Galactose
+し一11ydroxyprol ine
)Inosi++e
+Betaine
−D−Fructose 十
5ucrose
Treharose −I
C1uconate
−−1’ropionatc
MalnnaLe
−D(−)−Tartrate−
3orbitol
−Propylene glycol
−Ethanol +
n−Butanol +B
enzoate −m
−Hydroxybenzoate
−p−11ydroxybenzoate
−Pheno I
−Glycine
−L−3erine
+し−Lcucine
)L−1soleucine
+L−Valine
+L−Lysine
−L−Orn i th ine
−L−Histidine
+L−Phenylalanine
+Raff1nose
−Creatine
+Deoxycholate
−D−Glucuronat
e −本発明は、菌体外に著
量の蛋白質を生産するシュードモナス属菌で、特にシュ
ードモナスsp。(B) Growth of T-shaped deafness in each culture medium (D> Production of acid and gas (E) Assimilation of carbon source Acetate +5ucc
1nate +Fumarate
-L-Malate
+β-Hydroxybutylate
+Lactate
+C1trate +Set-Ke
toglutarate-Glycer
ol +shi Alanine
+L-Apartate
-L-Glutasate
+Arginine -L-Pr
oline 10L-Tyrosine +D-Fu
cose-Ma
ltose-
Cellobiosc
-Lactose
-O-8 rabinose
-^rabitol + 5tarch
-Inulin
-Ethyle++ glycol
-L-Threonine
-D-Ribose
+Mannitol +D-X
ylose tre^rabinose 10L-Rha
mnose-Gluc
ose 10D-Mannose + 1l-Galactose
+ Shiichi 11ydroxyprol ine
) Inosi++e
+Betaine
-D-Fructose 15ucrose Treharose -I
C1uconate
--1'ropionatc MalnnaLe
-D(-)-Tartrate- 3orbitol
-Propylene glycol
-Ethanol + n-Butanol +B
enzoate-m
-Hydroxybenzoate
-p-11ydroxybenzoate
-Pheno I
-Glycine
-L-3erine
+shi-Lcucine
) L-1 soleucine
+L-Valine
+L-Lysine
-L-Ornithine
-L-Histidine
+L-Phenylalanine
+Raff1nose
-Creatine
+Deoxycholate
-D-Glucuronat
e - The present invention relates to Pseudomonas bacteria that produce a significant amount of protein extracellularly, particularly Pseudomonas sp.
H5O1である。It is H5O1.
本発明のシュードモナス sp、H3O1を培養するこ
とにより著量生産した蛋白質の性質次第では、それ自体
食糧蛋白質やゲル化剤、膨化剤等の食品加工素材または
、ガラス様素材、紙、人工皮革等の表面加工等の工業素
材としての利用等産業上の有用性が非常に高い。Depending on the properties of the protein produced in large quantities by culturing Pseudomonas sp, H3O1 of the present invention, it can be used as a food protein, a food processing material such as a gelling agent, a swelling agent, or a glass-like material, paper, artificial leather, etc. It has very high industrial utility, such as its use as an industrial material for surface finishing.
また、本発明のンユードモナスsp、H3O1を遺伝子
組換えの宿主菌として利用した場合遺伝子組換えによる
生産物を効率良く菌体外に分泌することができるので、
遺伝子組換えにおける°宿主菌としてきわめてiぐれた
ものになるであろう。Furthermore, when Neudomonas sp, H3O1 of the present invention is used as a host bacterium for genetic recombination, the product of genetic recombination can be efficiently secreted outside the bacterial body.
It would be an extremely good host bacterium for genetic recombination.
この系は、医薬品、良質な食糧蛋白質やゲル化剤、膨化
剤等の食品加工素材または、ガラス様素材、紙、人工皮
革等の表面加工の工業素材などの生産手段としての活用
が期待できる。This system can be expected to be used as a production means for pharmaceuticals, high-quality food proteins, food processing materials such as gelling agents and swelling agents, and industrial materials for surface treatment such as glass-like materials, paper, and artificial leather.
以上のように本発明の有用性は産業上極めて意義深いも
のである。As described above, the usefulness of the present invention is extremely significant industrially.
以下に、実施例を挙げて本発明を更に具体的に説明する
。The present invention will be explained in more detail below by giving examples.
実施例1
前記第1表記載の5PC培地5ooII11を2Q容の
ジャーファーメンタ−に分注し、常法により 121℃
20分滅菌した後、冷却した。Example 1 The 5PC medium 5ooII11 described in Table 1 above was dispensed into a 2Q volume jar fermentor and heated to 121°C by a conventional method.
After sterilization for 20 minutes, it was cooled.
別に、 5PC培地51分注した試験管をオートクレー
ブすることにより滅菌し、これにシュードモナスsp、
H3O1を1白金耳摺種し、37℃で14時間振盪培養
した。この前培養物5mlをジャーファーメンタ−に接
種し、37℃48時間通気量0.51/を回転数400
rp+sで培養した。培養終了後、培養物に等lの0.
2N NaOHを加え攪拌1k 1010000rp
5分遠心分鑓処理して菌体を除き、上iffloOm
lに専属の101トリクロル酢酸を加え10分後 30
00rp+++810分間遠心分離して沈殿を集めた。Separately, a test tube containing 51 aliquots of 5PC medium was sterilized by autoclaving, and Pseudomonas sp.
One platinum loopful of H3O1 was seeded and cultured with shaking at 37°C for 14 hours. 5 ml of this preculture was inoculated into a jar fermenter at 37°C for 48 hours at an aeration rate of 0.51/rpm and a rotation speed of 400.
Cultured in rp+s. After incubation, add an equal volume of 0.
Add 2N NaOH and stir 1k 1010000 rpm
Centrifuge for 5 minutes to remove bacterial cells, and remove ifloOm.
Add proprietary 101 trichloroacetic acid to l and after 10 minutes 30
00rp+++8 Centrifugation was performed for 10 minutes and the precipitate was collected.
5%トリクロル酢酸で洗浄し、遠心分離に沈殿を集めI
N Na011で溶解した1&Lowry法によって定
量した。蛋白質は牛血清アルブミンに換算して示した。Wash with 5% trichloroacetic acid and collect the precipitate by centrifugation.
It was quantified by the 1&Lowry method dissolved in N Na011. Proteins are expressed in terms of bovine serum albumin.
その結果、菌体外に生産された蛋白質量は9g/Iであ
った。As a result, the amount of protein produced outside the bacterial cells was 9 g/I.
Claims (1)
菌。A new Pseudomonas bacterium that produces a significant amount of protein outside the bacterial body.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6128488A JPH01235581A (en) | 1988-03-15 | 1988-03-15 | Novel pseudomonas bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6128488A JPH01235581A (en) | 1988-03-15 | 1988-03-15 | Novel pseudomonas bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01235581A true JPH01235581A (en) | 1989-09-20 |
Family
ID=13166748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6128488A Pending JPH01235581A (en) | 1988-03-15 | 1988-03-15 | Novel pseudomonas bacteria |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01235581A (en) |
-
1988
- 1988-03-15 JP JP6128488A patent/JPH01235581A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pink et al. | Regulation of S-layer protein synthesis of Bacillus stearothermophilus PV72 through variation of continuous cultivation conditions | |
CN103710343B (en) | Novel DNA fragment and the recombinant vectors containing this fragment, the transformant utilizing them to transform to obtain and their application | |
CN112322533B (en) | Strain for producing efficient collagenase and application thereof | |
US4946789A (en) | Bacillus brevis strains and application thereof | |
JP5689560B1 (en) | New microorganism | |
Kyslik et al. | Plasmid burden in chemostat culture of Escherichia coli: its effect on the selection for overproducers of host enzymes | |
JPH01235581A (en) | Novel pseudomonas bacteria | |
WO2001016302A1 (en) | Novel thermostable collagen-digesting enzyme, novel microorganism producing the enzyme and process for producing the enzyme | |
US4430433A (en) | Production of aryl acylamidases | |
JPH01235585A (en) | Novel pseudomonas bacteria | |
JPH01235582A (en) | Novel pseudomonas bacteria | |
JPS6363375A (en) | Novel bacillus sp h023 | |
JPH01235583A (en) | Novel pseudomonas bacteria | |
JPH01235584A (en) | Novel pseudomonas bacteria | |
JPS6363374A (en) | Novel bacillus sp h1402 | |
JP4643873B2 (en) | Heat-resistant laccase and method for producing the same | |
JPS6363376A (en) | Novel bacillus sp h014 | |
JP2600090B2 (en) | Host vector system | |
JPH01174378A (en) | Novel microorganism of genus pseudomonas | |
JPH08168389A (en) | Production of material secreted by organic matter using blue-green alga | |
JP3433300B2 (en) | Highly producing yeast cell wall lytic enzyme and method for lysing yeast cell wall using the same | |
JP4752024B2 (en) | Cell wall degrading enzyme, producing microorganism, and protoplast preparation method using the same | |
JPH08107784A (en) | Transformation of alkalophilic bacterium of genus bacillus | |
CN116286565A (en) | Bacillus subtilis strain for high yield of alkaline protease and application thereof | |
JPH05260984A (en) | Production of 3-hydroxybutyric acid and/or its trimer |